Literature DB >> 31623872

Landscape of Noncoding RNA in Prostate Cancer.

Junjie T Hua1, Sujun Chen1, Housheng H He2.   

Abstract

The transcriptome of prostate cancer is highly heterogeneous, with noncoding transcripts being essential players. Long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) are two unique classes of noncoding RNA drawing increasing attention. Biologically, they have intriguing properties with important regulatory functions. Clinically, they present as promising biomarkers and therapeutic targets. Recent advancements in technologies have opened up new directions for noncoding RNA research, which include RNA-protein interaction, RNA secondary structure, and spatial transcriptomics. Furthermore, recent work has also evaluated the clinical applications of these noncoding RNAs in noninvasive liquid biopsy and RNA-based therapies. In this review, we summarize recent findings on lncRNAs and circRNAs in prostate cancer, discuss their clinical utilities, and highlight these exciting areas of research.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  biomarkers; circular RNA; long noncoding RNA; noncoding RNA; prostate cancer; therapeutics

Mesh:

Substances:

Year:  2019        PMID: 31623872     DOI: 10.1016/j.tig.2019.08.004

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  44 in total

1.  RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription.

Authors:  Jianjun Wang; Feng Huang; Yaxiang Shi; Qinghui Zhang; Song Xu; Yongliang Yao; Runqiu Jiang
Journal:  Gastric Cancer       Date:  2020-07-04       Impact factor: 7.370

2.  CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9.

Authors:  Yuwei Zhang; Fengping Liu; Yangkun Feng; Xinyu Xu; Yang Wang; Sha Zhu; Jian Dong; Shanchao Zhao; Bin Xu; Ninghan Feng
Journal:  Cancer Gene Ther       Date:  2022-06-27       Impact factor: 5.987

3.  SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling.

Authors:  Wenwen Zhang; Shuofei Yang; Datian Chen; Daolu Yuwen; Juan Zhang; Xiaowei Wei; Xin Han; Xiaoxiang Guan
Journal:  Cell Mol Life Sci       Date:  2022-01-07       Impact factor: 9.261

4.  Exosomal circKDM4A Induces CUL4B to Promote Prostate Cancer Cell Malignancy in a miR-338-3p-Dependent Manner.

Authors:  Guangyi Huang; Zeping Jiang; Wuan Zhu; Zhiyue Wu
Journal:  Biochem Genet       Date:  2022-08-05       Impact factor: 2.220

5.  CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis.

Authors:  Ozel Capik; Fatma Sanli; Ali Kurt; Onur Ceylan; Ilknur Suer; Murat Kaya; Michael Ittmann; Omer Faruk Karatas
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-03-22       Impact factor: 5.554

Review 6.  Role of noncoding RNA in drug resistance of prostate cancer.

Authors:  Lifeng Ding; Ruyue Wang; Danyang Shen; Sheng Cheng; Huan Wang; Zeyi Lu; Qiming Zheng; Liya Wang; Liqun Xia; Gonghui Li
Journal:  Cell Death Dis       Date:  2021-06-08       Impact factor: 8.469

7.  Circular RNA UBAP2 promotes the proliferation of prostate cancer cells via the miR-1244/MAP3K2 axis.

Authors:  Xiaodong Li; Baihetiya Azhati; Wenguang Wang; Mulati Rexiati; Chen Xing; Yujie Wang
Journal:  Oncol Lett       Date:  2021-04-21       Impact factor: 2.967

8.  Integrated Characterization of lncRNA-Immune Interactions in Prostate Cancer.

Authors:  Wei Hu; Yanru Wang; Zhixiao Fang; Wei He; Shengli Li
Journal:  Front Cell Dev Biol       Date:  2021-02-16

Review 9.  Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives.

Authors:  Huan-Huan Chen; Tie-Ning Zhang; Qi-Jun Wu; Xin-Mei Huang; Yu-Hong Zhao
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

10.  Vof16-miR-205-Gnb3 axis regulates hippocampal neuron functions in cognitively impaired diabetic rats.

Authors:  Wenfang Peng; Bojin Xu; Xiaoxu Ge; Juan Du; Liuqing Xi; Lili Xia; Qianqian Wang; Shan Huang
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.